Pinnacle Associates’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,775
| Closed | -$176K | – | 815 |
|
|
2021
Q3 | $176K | Sell |
10,775
-16,050
| -60% | -$262K | ﹤0.01% | 743 |
|
|
2021
Q2 | $451K | Sell |
26,825
-27,450
| -51% | -$462K | 0.01% | 562 |
|
|
2021
Q1 | $991K | Buy |
54,275
+3,975
| +8% | +$72.6K | 0.02% | 420 |
|
|
2020
Q4 | $915K | Buy |
50,300
+10,750
| +27% | +$196K | 0.02% | 406 |
|
|
2020
Q3 | $706K | Sell |
39,550
-61,065
| -61% | -$1.09M | 0.02% | 437 |
|
|
2020
Q2 | $1.8M | Sell |
100,615
-55,900
| -36% | -$1M | 0.04% | 283 |
|
|
2020
Q1 | $2.38M | Sell |
156,515
-4,625
| -3% | -$70.2K | 0.07% | 239 |
|
|
2019
Q4 | $3.18M | Buy |
161,140
+2,700
| +2% | +$53.3K | 0.07% | 254 |
|
|
2019
Q3 | $2.73M | Buy |
158,440
+10,383
| +7% | +$179K | 0.06% | 263 |
|
|
2019
Q2 | $2.62M | Buy |
148,057
+19,908
| +16% | +$352K | 0.06% | 272 |
|
|
2019
Q1 | $2.61M | Buy |
+128,149
| New | +$2.61M | 0.06% | 275 |
|